Lanx, a Broomfield, CO-based global spine company, closed a $15m Series C equity financing.
The round was led by new investor Credit Suisse Asset Management, with participation from existing equity investors Chicago Growth Partners, Goldman Sachs Private Equity Opportunities Fund, Noro-Moseley Partners and Oakwood Medical Investors, as well as new investor Hercules Technology Growth Capital.
The company intends to use the funds to to increase its sales and marketing infrastructure efforts and expand its product suite across both minimally invasive and core spinal fusion.
Led by Dan Gladney, CEO, Lanx focuses on developing and commercializing a line of fusion devices, with a platform of minimally invasive technologies including the TIMBERLINE™ Lateral Fusion System and ASPEN® MIS Fusion System. , and distributes its products throughout the world via a network of direct sales representatives and exclusive distributor partners.
The company’s portfolio of spine fusion solutions is available throughout the U.S., Mexico and Europe via a network of direct sales representatives and exclusive distributor partners.